Drug discovery

Research Field Drug discovery

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Research Field Informatics

AI Picks Parkinson’s

| James Strachan

Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?

Disease Area Drug discovery

Go Forth and Find a Flu Vaccine

| Kjetil Ree

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Tools & Techniques Drug discovery

Old Drugs, New Computational Tools

| Misagh Naderi

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

Research Field Drug discovery

Recognizing Friend from Foe

| Werner Cautreels

New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.

Research Field Cancer

Staying On Target

| Roisin McGuigan

What characteristics make a cancer therapy more likely to effectively treat disease?

Research Field Clinical trials

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Digital technologies could transform healthcare.

Tools & Techniques Drug discovery

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Disease Area Drug discovery

Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Outside the Lab Analytical science

Faster for Pharma

| Melissa Hanna-Brown

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register